Cigna explores shedding Medicare Advantage business 

Cigna explores shedding Medicare Advantage business 

DealsGovernmentHealth 06 November 2023, 6:28 pm 1 minute Reuters was first to report that U.S. health insurer Cigna Group (CI.N) is exploring the sale of its Medicare Advantage business, which manages government health insurance for people aged 65 and older, a move that would mark a reversal of its expansion in the sector.   Market Impact … Read more

US FDA finds control lapses at Moderna manufacturing plant 

US FDA finds control lapses at Moderna manufacturing plant 

Health 15 December 2023, 9:42 am 1 minute Reuters exclusively reported that U.S. drug regulators in September found quality control lapses at Moderna’s (MRNA.O) main factory including with equipment used to manufacture drug substance for its COVID-19 vaccine.  Market Impact Moderna in September said it was in talks with its partners that fill vials and … Read more

Eli Lilly could launch obesity drug in India next year

Eli Lilly could launch obesity drug in India next year

Health 28 February 2024, 12:55 pm 1 minute Reuters exclusively reported that U.S. drugmaker Eli Lilly LLY.N expects to launch Mounjaro, its blockbuster diabetes drug and wildly popular obesity treatment, in India as early as next year after it clears an ongoing regulatory review.  Market Impact The market opportunity is huge in the world’s most … Read more

Major Bayer shareholder Harris backs CEO’s focus on internal restructuring 

Major Bayer shareholder Harris backs CEO’s focus on internal restructuring 

Business & FinanceHealth 07 March 2024, 1:56 pm 1 minute Reuters exclusively reported that major Bayer shareholder Harris Associates came out in strong support of the drugmaker’s decision to suspend work on breaking up the diversified group, giving some breathing room to its embattled CEO.  Market Impact The news caused Bayer’s shares to significantly narrow … Read more

US FDA approves first drug for fatty liver disease NASH

US FDA approves first drug for fatty liver disease NASH

Health 14 March 2024, 2:54 pm 1 minute Reuters was first to report on the FDA approving Madrigal Pharmaceuticals’ drug Rezdiffra, an oral drug to treat a fatty liver disease known as non-alcoholic steatohepatitis (NASH). The approval was the first of its kind.  Market Impact The company’s shares surged 24% in extended trading. Article Tags … Read more

Congo gets first desperately needed mpox vaccines, but vaccination campaign faces huge challenges

Congo gets first desperately needed mpox vaccines, but vaccination campaign faces huge challenges

Johannesburg — The Democratic Republic of Congo, at the epicenter of a global health emergency declared over a still-growing mpox outbreak, received a first delivery of 99,000 vaccines for the virus Thursday, with a second delivery of 101,000 expected Saturday, the head of the World Health Organization said.  Congolese health officials tell CBS News they … Read more

Boar’s Head faces multiple lawsuits after its deli meat is linked to deadly listeria outbreak

Boar’s Head faces multiple lawsuits after its deli meat is linked to deadly listeria outbreak

Boar’s Head faces at least seven lawsuits following the August recall of millions of pounds of its deli meat after the food company’s products were linked to a deadly listeria outbreak.  The latest listeria outbreak has grown to 57 hospitalizations in 18 states linked to recalled products from Boar’s Head plant in Jarratt, Virginia. At … Read more